Current Edition

COVID-19

Novavax, fashionably late to the COVID-19 vaccine party, could still reap $5B in 2022: analyst

After a winding path to a coronavirus vaccine launch that still hasn’t reached the U.S., Novavax’s program could be destined to reap billions of dollars …

Continue Reading →
COVID

Teva survey finds COVID has ‘widened the chasm’ on health disparities

By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try …

Continue Reading →
clinical trials

Operationalising Decentralised Clinical Trials (DCTs)

The Challenges and Change Management Approaches, Considering Trial Designs and Timelines with Decentralisation Methods at the Forefront While components of fully decentralised clinical trials and …

Continue Reading →
COVID-19

Plain Language Summaries of Publications – What Has COVID-19 Taught Us?

The COVID-19 pandemic has significantly impacted the whole world and the public has had to struggle with understanding scientific data on a daily basis. The …

Continue Reading →
Area Extension

B Medical Systems – Production Area Extension

The new factory extension of B Medical Systems, a global leader in the vaccine cold chain, was inaugurated by the Honourable Luxembourg Minister of Economy, …

Continue Reading →